| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Doyle James Edward serves as a Director at EXAS. Across recent SEC filings that breaks down to 1 buy and 14 sells.
Historically, Doyle James Edward's trades have earned a strong insider score of 75/100 across 7 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +44.4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2019 | EXAS Exact Sciences Corp | Director | Sell | 2,808 | $117.93 | $331,147.44 | -7.5% | |
| Feb 28, 2019 | EXAS Exact Sciences Corp | Director | Sell | 2,000 | $96.00 | $192,000.00 | -5.4% | |
| Jul 30, 2018 | EXAS Exact Sciences Corp | Director | Sell | 1,318 | $58.86 | $77,577.48 | -3.4% | |
| Apr 10, 2018 | EXAS Exact Sciences Corp | Director | Sell | 3,098 | $40.97 | $126,925.06 | -8.1% | |
| Mar 8, 2016 | EXAS Exact Sciences Corp | Director | Buy | 5,000 | $6.43 | $32,150.00 | +30.4% |